Novocure (NASDAQ: NVCR) reported Q1 EPS of ($0.31), $0.18 better than the analyst estimate of ($0.49). Revenue for the quarter came in at $155 million versus the consensus estimate of $147.57 million.

For earnings history and earnings-related data on Novocure (NVCR) click here.